UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 4.

Weller, Michael; Tabatabai, G; Kästner, B; Felsberg, J; Steinbach, J P; Wick, A; Schnell, O; Hau, P; Herrlinger, U; Sabel, M C; Wirsching, H G; Ketter, R; Bähr, O; Platten, M; Tonn, J C; Schlegel, U; Marosi, C; Goldbrunner, R; Stupp, R; Homicsko, K; Pichler, J; Nikkhah, G; Meixensberger, J; Vajkoczy, P; Kollias, S; Hüsing, J; Reifenberger, G; Wick, W (2015). MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical Cancer Research, 21(9):2057-2064.

Braun, S; Oppermann, H; Mueller, A; Renner, C; Hovhannisyan, A; Baran-Schmidt, R; Gebhardt, R; Hipkiss, A; Thiery, J; Meixensberger, J; Gaunitz, F (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biology & Therapy, 13(7):487-495.

Wick, W; Platten, M; Meisner, C; Felsberg, J; Tabatabai, G; Simon, M; Nikkhah, G; Papsdorf, K; Steinbach, J P; Sabel, M; Combs, S E; Vesper, J; Braun, C; Meixensberger, J; Ketter, R; Mayer-Steinacker, R; Reifenberger, G; Weller, M (2012). Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncology, 13(7):707-715.

Wess, C; Sarnthein, J; Krayenbühl, N; Scholz, M; Kunze, E; Meixensberger, J (2010). Spectral iEEG markers precede SSEP events during surgery for subarachnoid hemorrhage. Clinical Neurophysiology, 121(12):2172-2176.

This list was generated on Fri Jul 21 03:18:23 2017 CEST.